Meetings

During this live session, faculty will present on each topic and then answer questions and share their experiences related to GVHD and infectious complications. 

The goals of the conference are to review the state of the science and basic, translational and clinical research related to relapse after allogeneic and autologous HSCT, along with cellular therapies.

The pharmacy journal club webinar consists of two, 30-minute journal club presentations. The November Journal Club sessions will cover PTCy-based GVHD Prophylaxis after mismatched unrelated donor peripheral blood stem cell transplant and CAR-T Therapy for Richter Transformation.

Presented by the ASTCT Survivorship SIG, this panel-based webinar will focus on identifying our current physical assessment tools to guide the practice of pre-HCT evaluation of physical function.

The clinical, logistical and administrative landscape behind BMT therapies can vary significantly across the world. In this webinar, we will use case studies to highlight country-specific considerations with regard to donor selection and survivorship.

Sexual dysfunction is a well-known adverse event after transplant; however, is under-recognized and under-treated. We will review barriers to discussions surrounding sexual health after transplant as well as strategies to approach this and the role of a dedicated sexual health clinic.